Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Green Discloses License Negotiations with Seed Company

Premium

Rosetta Green announced this week that it is negotiating a deal under which “one of the world's largest seed companies” would license a “limited” number of microRNAs identified by Rosetta Green as potentially improving key traits within an undisclosed crop plant.

If an agreement is signed and the undisclosed seed company markets products incorporating the miRNA technology, Rosetta Green would be paid milestones and royalties.

Rosetta Green said that “if the negotiation between the parties will be successful, an agreement will be signed and executed in the near term,” but added that there is no guarantee this will occur.

The Scan

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.

Vitamin D From Tomatoes

According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D.

Cause Not Yet Spotted

NPR reports that a new study was unable to find a cause for persistent long COVID symptoms.

PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele

In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.